Amgen osteoporosis drug Prolia is working to appeal to menopausal women with a new TV ad, but it's leaving behind its celebrity spokeswoman.
Move over, Siri and Alexa: There’s a new voice in town. Meet Sophia, Novo Nordisk’s first chatbot built specifically for people with diabetes.
At least three new emergency epinephrine marketers are challenging longtime market leader Mylan and its EpiPen.
AZ struck out in May in trying to expand Fasenra into COPD. But it does have new long-term data that could bolster the drug in its current indication.
The policy revelation shows just how eager Novartis is in addressing some latest ethics shortfalls.
Merck is already in phase 3 testing for its next-generation pneumococcal vaccine, and Pfizer's CFO said his company is "all in" on advancing its…
AstraZeneca’s latest data on its triple-combination COPD candidate may not do much to help it against rival GlaxoSmithKline.
Astellas is reupping its sponsorship of ABC’s “Dancing With the Stars,” partnering with former pro boxer and TV personality Laila Ali.
The new eczema data came a month ahead of an expected FDA decision on the drug's fate in asthma.
Sticker prices in drug ads might be off the table again, thanks to some in the U.S. House of Representatives.
